In December 2015, 34 patients’ groups from across Latin America gathered in Buenos Aires (Argentina) and actively participated in the Latin American Patient Advocacy Groups’ Summit on Biotherapeutics, co-hosted by IAPO and the Global Alliance for Patient Access (GAfPA), sponsored by AbbVie.

Viu-se um amplo consenso de que as agências reguladoras e os grupos de pacientes precisam colaborar mais intimamente na América Latina, no seminário multilateral que ocorreu ontem no Rio de Janeiro, Brasil.